PranaX, a Houston, USA-based biotech specializing in exosome-based regenerative therapies, has appointed Phillip Maderia as ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company specializing in novel antibody therapeutics for immunology ...

USA-based Emergent BioSolutions (NYSE: EBS) and Swiss vaccines firm Rocketvax have announced an agreement. One part of the ...

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

California commercial-stage biopharma firm Geron Corporation (Nasdaq: GERN) has announced that Dr John “Chip” Scarlett, ...

Independent French drugmaker Pierre Fabre Laboratories and Switzerland-based RedRidge Bio have announced an exclusive R&D ...

ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 ...

Sweden-based women’s health company Gedea Biotech has completed a clinical trial, the NEFERTITI-2 study, for the treatment of ...

Japanese drugmaker Ono (TYO: 4528) has entered into a license agreement with USA-based Ionis Pharmaceuticals (Nasdaq: IONS) ...

US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% ...

Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, ...

UK-based Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, today ...